Singapore markets open in 3 hours 18 minutes

Newland Pharmaceutical Co., Ltd. (301277.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.98+0.10 (+0.78%)
At close: 03:04PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
127,382
158,979
132,305
114,978
118,455
-
Depreciation & amortisation
22,976
31,080
24,242
20,865
17,951
-
Stock-based compensation
3,709
-
-
3,709
1,465
-
Change in working capital
-138,729
88,799
-86,898
-108,494
-96,969
-
Inventory
27,596
21,604
25,049
-29,155
-17,443
-
Other working capital
-8,615
162,945
8,503
23,682
30,900
-
Other non-cash items
6,947
1,673
7,044
6,705
3,540
-
Net cash provided by operating activities
36,667
259,460
82,845
49,079
47,858
-
Cash flows from investing activities
Investments in property, plant and equipment
-45,282
-96,515
-74,343
-25,397
-16,958
-
Purchases of investments
-3,855,000
-3,693,200
-700,000
-9,500
-
-15,025
Sales/maturities of investments
4,300
3,822,659
8,833
1,002
-
20,000
Net cash used for investing activities
-40,884
33,481
-765,472
-33,830
-16,839
-
Net change in cash
9,394
223,507
16,118
-5,936
17,297
-
Cash at beginning of period
23,677
46,516
30,398
36,335
19,037
-
Cash at end of period
33,072
270,023
46,516
30,398
36,335
-
Free cash flow
Operating cash flow
36,667
259,460
82,845
49,079
47,858
-
Capital expenditure
-45,282
-96,515
-74,343
-25,397
-16,958
-
Free cash flow
-8,615
162,945
8,503
23,682
30,900
-